HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis.

AbstractOBJECTIVE:
To compare a simultaneous vs sequential approach to residual post chemotherapy mass resections in metastatic testis cancer.
METHODS:
A retrospective review was performed of patients who underwent retroperitoneal and thoracic/cervical resection of post chemotherapy residual masses between 2002 and 2018. Group 1: "Simultaneous" (Combined Retroperitoneal and Thoracic/Cervical resections on the same date); Group 2: "Sequential" (Retroperitoneal and Thoracic/Cervical resections at separate dates).
RESULTS:
During the study period, 35 simultaneous and 17 sequential resections were performed. The median age at surgery was 28 years (Range 16-61). The median follow-up from last surgical procedure was 62.7 months (Range 0.4-194). Histology revealed teratoma in 38 (73.1%) patients, necrosis in 8 (15.4%) and viable tumor in 6 (11.5%). Discordant pathology findings between thoracic/cervical and abdominal resections were noted in 16 (30.8%) patients. No differences were observed between the simultaneous vs sequential groups in median operating time (585 minutes vs 545 minutes, P = .64), blood loss (1300 vs 1300 mls, P = .42), or length of stay (9 vs 11 days, P = .14). There was no difference between the 5-year (65.7% vs 68.6%) relapse-free survival between the 2 groups (P = .84) or the 5-year (88.6% vs 100%) overall and disease-specific survival (P = .25).
CONCLUSION:
Simultaneous resection of retroperitoneal and thoracic/cervical post chemotherapy metastases is a feasible in some patients. It requires multidisciplinary collaboration and a longer primary procedure.
AuthorsGregory J Nason, Laura Donahoe, Marc de Perrot, Ishan Aditya, Michael A S Jewett, Philip L Bedard, Aaron R Hansen, Peter Chung, Padraig Warde, Lynn Anson-Cartwright, Joan Sweet, Martin O'Malley, Eshetu G Atenafu, Robert J Hamilton
JournalUrology (Urology) Vol. 138 Pg. 69-76 (04 2020) ISSN: 1527-9995 [Electronic] United States
PMID32004556 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chemotherapy, Adjuvant
  • Feasibility Studies
  • Humans
  • Male
  • Middle Aged
  • Neck Dissection (adverse effects, methods, statistics & numerical data)
  • Neoadjuvant Therapy
  • Neoplasm, Residual
  • Neoplasms, Germ Cell and Embryonal (secondary, therapy)
  • Patient Care Team
  • Postoperative Complications (epidemiology, etiology)
  • Retroperitoneal Space (surgery)
  • Retrospective Studies
  • Testicular Neoplasms (pathology, secondary, therapy)
  • Thoracic Surgical Procedures (adverse effects, methods, statistics & numerical data)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: